1. Home
  2. XELB vs NXL Comparison

XELB vs NXL Comparison

Compare XELB & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

BUY

Current Price

$0.36

Market Cap

8.4M

Sector

Miscellaneous

ML Signal

BUY

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

HOLD

Current Price

$1.87

Market Cap

7.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XELB
NXL
Founded
2011
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Medical Specialities
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
7.5M
IPO Year
2011
2022

Fundamental Metrics

Financial Performance
Metric
XELB
NXL
Price
$0.36
$1.87
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $4.00
N/A
AVG Volume (30 Days)
1.4M
★ 2.0M
Earning Date
11-18-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 48.37
39.76
EPS
N/A
★ N/A
Revenue
N/A
★ $301,647.00
Revenue This Year
$30.13
$14.37
Revenue Next Year
$99.55
$100.00
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 78.78
52 Week Low
$0.27
$0.22
52 Week High
$2.47
$99.00

Technical Indicators

Market Signals
Indicator
XELB
NXL
Relative Strength Index (RSI) 26.27 30.65
Support Level $0.27 $0.22
Resistance Level $1.16 $5.36
Average True Range (ATR) 0.09 0.43
MACD -0.00 0.02
Stochastic Oscillator 15.71 1.35

Price Performance

Historical Comparison
XELB
NXL

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.

Share on Social Networks: